PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm to Present at Evercore ISI HealthCONx Conference, page-156

  1. 9,819 Posts.
    lightbulb Created with Sketch. 1249
    Interesting to see some reasonable interest come in at closing auction. Teething issues with the PAR team co-ordinating key messages or continuous disclosure issues rife ?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.